Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2008 1
2013 1
2015 1
2016 3
2017 1
2018 2
2019 4
2020 5
2021 3
2022 5
2023 6
2024 14
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ; SYNERGY-NASH Investigators. Loomba R, et al. N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8. N Engl J Med. 2024. PMID: 38856224 Clinical Trial.
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.
Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F, Bedossa P, Sun X, Hoshida Y, Koduru SV, Contaifer D Jr, Warncke UO, Wijesinghe DS, Sanyal AJ. Asgharpour A, et al. J Hepatol. 2016 Sep;65(3):579-88. doi: 10.1016/j.jhep.2016.05.005. Epub 2016 May 31. J Hepatol. 2016. PMID: 27261415 Free PMC article.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. Among authors: asgharpour a. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249 Free PMC article.
Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
Gawrieh S, Dasarathy S, Tu W, Kamath PS, Chalasani NP, McClain CJ, Bataller R, Szabo G, Tang Q, Radaeva S, Barton B, Nagy LE, Shah VH, Sanyal AJ, Mitchell MC; AlcHepNet Investigators. Gawrieh S, et al. J Hepatol. 2024 May;80(5):684-693. doi: 10.1016/j.jhep.2024.01.031. Epub 2024 Feb 10. J Hepatol. 2024. PMID: 38342441 Free PMC article. Clinical Trial.
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort Study.
Chun HS, Lee M, Lee HA, Park ES, Choi JY, Baek HS, Kim TH, Lin H, Cheuk-Fung Yip T, Lee HW, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Boon-Bee Goh G, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison S, Fournier-Poizat C, Lai-Hung Wong G, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Jun Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Sau-Wai Chan M, Romero-Gomez M, Wai-Sun Wong V, Kim SU. Chun HS, et al. Among authors: asgharpour a. Clin Gastroenterol Hepatol. 2025 Jul 10:S1542-3565(25)00569-5. doi: 10.1016/j.cgh.2025.06.025. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40645391
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
Zhou XD, Kim SU, Yip TC, Petta S, Nakajima A, Tsochatzis E, Boursier J, Bugianesi E, Hagström H, Chan WK, Romero-Gomez M, Calleja JL, de Lédinghen V, Castéra L, Sanyal AJ, Goh GB, Newsome PN, Fan J, Lai M, Fournier-Poizat C, Lee HW, Wong GL, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, Saint-Loup M, Canivet CM, Lara-Romero C, Gallego-Duràn R, Asgharpour A, Teh KK, Mahgoub S, Chan MS, Lin H, Liu WY, Targher G, Byrne CD, Wong VW, Zheng MH; VCTE-Prognosis Study Group. Zhou XD, et al. Among authors: asgharpour a. Gut. 2024 Oct 7;73(11):1883-1892. doi: 10.1136/gutjnl-2024-333074. Gut. 2024. PMID: 39089860
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease.
Yip TC, Lee HW, Lin H, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW. Yip TC, et al. Among authors: asgharpour a. J Hepatol. 2025 Aug;83(2):304-314. doi: 10.1016/j.jhep.2025.01.014. Epub 2025 Jan 23. J Hepatol. 2025. PMID: 39863175 Free article.
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.
Lai JC, Yang B, Lee HW, Lin H, Tsochatzis EA, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Duràn R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castera L, Lai M, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, Saint-Loup M, Llop E, Teh KKJ, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gómez M, Kim SU, Wong VW, Yip TC. Lai JC, et al. Among authors: asgharpour a. Gut. 2025 Jul 17:gutjnl-2025-334981. doi: 10.1136/gutjnl-2025-334981. Online ahead of print. Gut. 2025. PMID: 40541300
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt.
Houston K, Duong N, Sterling RK, Asgharpour A, Bullock S, Weinland S, Keller N, Smirnova E, Khan H, Matherly S, Wedd J, Lee H, Siddiqui M, Patel V, Arias A, Kumaran V, Lee S, Sharma A, Khan A, Imai D, Levy M, Bruno D. Houston K, et al. Among authors: asgharpour a. Liver Transpl. 2024 Dec 1;30(12):1281-1288. doi: 10.1097/LVT.0000000000000407. Epub 2024 May 23. Liver Transpl. 2024. PMID: 38775570
56 results